Over the last decade neural networks have become an efficient method for da
ta analysis in the field of drug discovery. The early problems encountered
with neural networks such as overfitting and overtraining have been address
ed resulting in a technique that surpasses traditional statistical methods.
Neural networks have thus largely lived up to their promise, which was to
overcome QSAR statistical problems. The next revolution in QSAR will no dou
bt involve research into producing better descriptors used in these studies
to improve our ability to relate chemical structure to biological activity
. This review focuses on the applications of neural network methods and the
ir development over the last five years. (C) Elsevier, Paris.